Skip to main content
Clinical Trials/NCT04009161
NCT04009161
Active, not recruiting
Not Applicable

Osteoradionecrosis Rate in Patients Undergoing Radiotherapy for Head and Neck Cancer Treatment: a Perspective Clinical Study.

Catholic University of the Sacred Heart1 site in 1 country160 target enrollmentMarch 14, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
Catholic University of the Sacred Heart
Enrollment
160
Locations
1
Primary Endpoint
Osteoradionecrosis rate following pre-radiotherapy tooth extraction
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Objectives High-dose radiotherapy (RT) for head and neck cancer has significant adverse effects on maxillofacial tissues, among which osteoradionecrosis (ORN) is the most severe and potentially life-threatening. Although tooth extractions seem to be the main risk factor, few perspective studies evaluated protocols to minimize the ORN risk due to extractions. The aim of this study is to evaluate incidence and risk factors of ORN in a cohort of patients receiving tooth extractions before RT and evaluate an algorithm about extraction decision.

Methods One-hundred ten patients were consecutively recruited in this study: impacted third molars with radiographic sign of pericoronitis, teeth with periapical lesions, unrestorable teeth, periodontally compromised teeth (pocket probing depth >5 mm, clinical attachment loss > 8 mm, grade 2 tooth mobility, II grade furcation involvement) were extracted under antibiotic prophylaxis. A 15-days interval between the last tooth extraction and the beginning of RT was recommended. Patients were visited at 15 days, 1, 3 and 6 months after the beginning of RT. Data of patients with a minimum of 6 months follow-up are presented in this report. ORN was defined as irradiated exposed necrotic bone, without healing for 3 months, in absence of cancer recurrence. The protocol was approved by the Ethic Committee of Catholic University - Fondazione Policlinico Gemelli (Prot. OHHN-1, ID-2132).

Registry
clinicaltrials.gov
Start Date
March 14, 2017
End Date
June 1, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carlo Lajolo

Principal Investigator

Catholic University of the Sacred Heart

Eligibility Criteria

Inclusion Criteria

  • Patients willing to sign the informed consent form
  • Patients with diagnosis of HNC, with specific prescription of local radiotherapy, both for curative and palliative purpose, with or without chemotherapic treatment.
  • Patient with diagnosis of HNC, with specific prescription of local radiotherapy as an adjuvant to surgical resection, with or without chemotherapic treatment.

Exclusion Criteria

  • Patients participating to other clinical studies
  • Patients who refuse to participate in the study
  • Patients unable to attend the ambulatory visits scheduled by the protocol

Outcomes

Primary Outcomes

Osteoradionecrosis rate following pre-radiotherapy tooth extraction

Time Frame: 60 months after the beginning of RT

Osteoradionecrosis Incidence

Time Frame: 60 months after the beginning of RT

To evaluate the ORN incidence in a population irradiated for Head and Neck Cancer.

Secondary Outcomes

  • Extraction site: number of tooth extractions for each site (anterior and posterior maxilla or mandible and specific tooth number) and percentage of ORN for each site.(60 months after the beginning of RT)
  • Time interval between extraction and Radiotherapy: days between every tooth extraction and the beginning of RT.(60 months after the beginning of RT)
  • Surgical protocol 3: Osteotomy per each extracted tooth (YES/NO) and percentage of ORN per each type of procedure.(60 months after the beginning of RT)
  • Radiation dose to the post-extractive site (Gy of radiation received by every post-extractive site)(60 months after the beginning of RT)
  • Reason for tooth extraction: number of tooth extraction for each cause under the protocol (caries, periodontal disease, endodontic lesions, pericoronitis, fracture) and percentage of ORN for each cause.(60 months after the beginning of RT)
  • Age of every patients at the beginning of RT(At baseline)
  • Number of participants undergoing concurrent chemotherapy (neoadjuvant or concomitant)(During treatment)
  • Surgical protocol 1: Flap elevation per each extracted tooth (YES/NO) and percentage of ORN per each type of procedure.(60 months after the beginning of RT)
  • Surgical protocol 2: Primary intention closure achievement per post-extractive site (YES/NO) and percentage of ORN per each type of procedure.(60 months after the beginning of RT)
  • Sex (male, female) of every patients at the beginning of RT(At baseline)

Study Sites (1)

Loading locations...

Similar Trials